Clinical Pharmacology Considerations and Modeling of CAR-T Cell Therapies Using Monolix®
The In Silico Revolution: How AI is Fixing Pharma’s $1 Billion Problem
Hiring Challenges and Opportunities in 2025: Building Stronger Model-Informed Teams
FDA Modeling and AI in Generic Drug Development 2025: AI and Quantitative Medicine – Presentations
Model-Informed Drug Development: Deciphering Complexity for Better Decisions
Model-Informed Drug Development
🌟 CAiRL Learning Labs – Session 4 | Model Informed Drug Development in the AI Era 🚀
CITC 2024 – D2S03 – Clinical Pharmacology: Early Drug Development
FDA Clinical Investigator Training Course 2024: Clinical Pharmacology: Early Drug Development
Alex MacDonald, PhD, VP, Discusses How his Team uses MIDD to Support Biotechs
Certara’s Investor Circuit Buzz: Biosimulation Secrets Unveiled!
How Regulatory-Ready is Model-Informed Drug Development?
Longitudinal Model-Based Meta-Analysis (MBMA) Comprehensive MonolixSuite Tutorial with Case Studies
Longitudinal Model-Based Meta-Analysis (MBMA): A Comprehensive MonolixSuite Tutorial
An Overview of the Draft ICHM15 Guideline on Model-Informed Drug Development
DDI Risk Assessment to Inform Your Label Optimize Your Program Timeline & Budget with PBPK Modeling
What Is Model-Informed Drug Development? - Chemistry For Everyone
Certara Strikes Gold: Over 100 Papers Published & Top Scientists Ranked!
Certara Rocks the Stage at Stephens Investment Conference: What's Ahead?